This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4pl5
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='4pl5' size='340' side='right'caption='[[4pl5]], [[Resolution|resolution]] 3.40Å' scene=''> | <StructureSection load='4pl5' size='340' side='right'caption='[[4pl5]], [[Resolution|resolution]] 3.40Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4pl5]] is a 4 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4pl5]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4PL5 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4PL5 FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=31L:3-METHOXY-5-METHYL-4-(MORPHOLIN-4-YL)BIPHENYL-4-OL'>31L</scene>, <scene name='pdbligand=ADP:ADENOSINE-5-DIPHOSPHATE'>ADP</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=PEU:2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80-HEPTACOSAOXADOOCTACONTAN-82-OL'>PEU</scene> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=31L:3-METHOXY-5-METHYL-4-(MORPHOLIN-4-YL)BIPHENYL-4-OL'>31L</scene>, <scene name='pdbligand=ADP:ADENOSINE-5-DIPHOSPHATE'>ADP</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=PEU:2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80-HEPTACOSAOXADOOCTACONTAN-82-OL'>PEU</scene></td></tr> |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4pl5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4pl5 OCA], [https://pdbe.org/4pl5 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4pl5 RCSB], [https://www.ebi.ac.uk/pdbsum/4pl5 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4pl5 ProSAT]</span></td></tr> | |
| - | + | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/ERN1_MOUSE ERN1_MOUSE] Senses unfolded proteins in the lumen of the endoplasmic reticulum via its N-terminal domain which leads to enzyme auto-activation. The active endoribonuclease domain splices XBP1 mRNA to generate a new C-terminus, converting it into a potent unfolded-protein response transcriptional activator and triggering growth arrest and apoptosis.<ref>PMID:11850408</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 28: | Line 26: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: | + | [[Category: Mus musculus]] |
| - | [[Category: Al-awar | + | [[Category: Al-awar R]] |
| - | [[Category: Chiovitti | + | [[Category: Chiovitti D]] |
| - | [[Category: Duffy | + | [[Category: Duffy N]] |
| - | [[Category: Patterson | + | [[Category: Patterson JB]] |
| - | [[Category: Sanches | + | [[Category: Sanches M]] |
| - | [[Category: Sicheri | + | [[Category: Sicheri F]] |
| - | [[Category: Talukdar | + | [[Category: Talukdar M]] |
| - | [[Category: Thevakumaran | + | [[Category: Thevakumaran N]] |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Revision as of 07:16, 8 February 2023
Crystal structure of murine IRE1 in complex with OICR573 inhibitor
| |||||||||||
